ZOETIS (ZTS, $159.24) was a top loser over the last three months, falling -1 to $159.24 per share. A.I.dvisor analyzed 291 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending April 30, 2024, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.